Skip to main content
  1. Market Insights
  2. Health
  3. OTC Pharmaceuticals

Digestives & Intestinal Remedies - Tanzania

Tanzania
  • In Tanzania, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$17.30m.
  • It is projected to experience an annual growth rate of 7.60% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, China generates the highest revenue in this market, reaching US$4.41bn in 2024.
  • In terms of per capita figures, the revenue per person in Tanzania amounts to US$0.25 in 2024.
  • Sales of Digestives & Intestinal Remedies in the OTC Pharmaceuticals market in Tanzania are soaring, driven by growing awareness of digestive health and changing dietary habits.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope

  • Natural and synthetic agents
  • Digestive medicines
  • Remedies against gastrointestinal complaints

Out-Of-Scope

  • Prescription medicines
  • Homeopathic remedies
  • Tea
Digestives & Intestinal Remedies: market data & analysis - Cover

Market Insights report

Digestives & Intestinal Remedies: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Digestives & Intestinal Remedies market in Tanzania is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising awareness and prevalence of digestive health issues in the country.

    Customer preferences:
    Customers in Tanzania are increasingly turning to natural and herbal remedies for digestive health issues. This shift in preferences can be attributed to the rising awareness of the potential side effects of conventional medications and the desire for more holistic and sustainable solutions. Additionally, there is a growing demand for products that are locally sourced and produced, as customers place importance on supporting local businesses and the economy.

    Trends in the market:
    One of the key trends in the Digestives & Intestinal Remedies market in Tanzania is the increasing demand for probiotics and dietary supplements. Probiotics are known for their positive effects on gut health and are becoming more popular among consumers seeking to improve their digestive function. Dietary supplements, such as fiber supplements, are also gaining traction as they are seen as an effective way to address common digestive issues.Another trend in the market is the rise of herbal remedies. Traditional herbal medicine has a long history in Tanzania, and many consumers are turning to herbal remedies for digestive health issues. This trend is driven by the belief that herbal remedies are natural, safe, and have fewer side effects compared to conventional medications.

    Local special circumstances:
    Tanzania has a rich biodiversity, with a wide range of medicinal plants that have been traditionally used for digestive health issues. This abundance of natural resources provides an opportunity for local manufacturers to develop and produce herbal remedies that cater to the specific needs of the Tanzanian market. Additionally, the government has been supportive of the traditional medicine sector, providing incentives and regulations to promote the development and use of herbal remedies.

    Underlying macroeconomic factors:
    The growth of the Digestives & Intestinal Remedies market in Tanzania is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and improved access to healthcare services. As a result, consumers are more willing to spend on healthcare products, including those for digestive health.Furthermore, the increasing prevalence of digestive health issues in Tanzania is driving the demand for Digestives & Intestinal Remedies. Factors such as changes in diet, stress, and sedentary lifestyles contribute to the rising incidence of digestive disorders, creating a need for effective remedies.In conclusion, the Digestives & Intestinal Remedies market in Tanzania is growing due to customer preferences for natural and herbal remedies, the increasing demand for probiotics and dietary supplements, the rich biodiversity of the country, and the underlying macroeconomic factors such as economic growth and the rising prevalence of digestive health issues.

    Key Players

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Sales Channels

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

    Health

    Access more Market Insights on Health topics with our featured report

    Digestives & Intestinal Remedies: market data & analysis - BackgroundDigestives & Intestinal Remedies: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.